Barcelona, Spain

Maria Jose Pretel Sanchez

This inventor holds 1 USPTO granted patent. Top assignee: Laboratories Del Dr. Esteve S.a.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maria Jose Pretel Sanchez. Retrieved from https://idiyas.com/inventor/maria-jose-pretel-sanchez

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Maria Jose Pretel Sanchez: Innovator in Sigma Receptor Inhibitors

Introduction

Maria Jose Pretel Sanchez is a notable inventor based in Barcelona, Spain. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that act as sigma receptor inhibitors. Her work is crucial for advancing treatments for various diseases.

Latest Patents

Maria Jose Pretel Sanchez holds a patent for a compound known as 5-methyl-1-(naphthalen-2-yl)-1H-pyrazoles. This invention relates to compounds that can be utilized as sigma receptor inhibitors. The patent outlines methods for the preparation of these compounds and their potential uses as medicaments, especially for treating or preventing sigma receptor-mediated diseases or conditions.

Career Highlights

She is currently associated with Laboratories Del Dr. Esteve S.A., where she continues her research and development efforts. Her innovative work has positioned her as a key figure in her field, contributing to advancements in pharmaceutical applications.

Collaborations

Maria Jose Pretel Sanchez has collaborated with esteemed colleagues, including Antoni Torrens Jover and Maria Rosa Cuberes-Altisent. These partnerships have enhanced her research and broadened the impact of her inventions.

Conclusion

Maria Jose Pretel Sanchez exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions to sigma receptor inhibitors are paving the way for new therapeutic options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…